155 related articles for article (PubMed ID: 30169431)
1. Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients.
Tan SY; Najita J; Li X; Strazzulla LC; Dunbar H; Lee MY; Seery VJ; Buchbinder EI; Tawa NE; McDermott DF; Lee SJ; Atkins MB; Kim CC
Melanoma Res; 2019 Feb; 29(1):70-76. PubMed ID: 30169431
[TBL] [Abstract][Full Text] [Related]
2. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
3. Tumor Mitotic Rate and Association with Recurrence in Sentinel Lymph Node Negative Stage II Melanoma Patients.
Laks S; Meyers MO; Deal AM; Frank JS; Stitzenberg KB; Yeh JJ; Thomas NE; Ollila DW
Am Surg; 2017 Sep; 83(9):972-978. PubMed ID: 28958277
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant vemurafenib in resected, BRAF
Maio M; Lewis K; Demidov L; Mandalà M; Bondarenko I; Ascierto PA; Herbert C; Mackiewicz A; Rutkowski P; Guminski A; Goodman GR; Simmons B; Ye C; Yan Y; Schadendorf D;
Lancet Oncol; 2018 Apr; 19(4):510-520. PubMed ID: 29477665
[TBL] [Abstract][Full Text] [Related]
6. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
7. Status of the Regional Nodal Basin Remains Highly Prognostic in Melanoma Patients with In-Transit Disease.
Gonzalez AB; Jakub JW; Harmsen WS; Suman VJ; Markovic SN
J Am Coll Surg; 2016 Jul; 223(1):77-85.e1. PubMed ID: 27118347
[TBL] [Abstract][Full Text] [Related]
8. Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases.
Seifried S; Haydu LE; Quinn MJ; Scolyer RA; Stretch JR; Thompson JF
Ann Surg Oncol; 2015; 22(6):1959-66. PubMed ID: 25384702
[TBL] [Abstract][Full Text] [Related]
9. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
10. The management of cervical lymph nodes in patients with cutaneous melanoma.
Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
[TBL] [Abstract][Full Text] [Related]
11. Subungual Melanoma of the Hand.
Chakera AH; Quinn MJ; Lo S; Drummond M; Haydu LE; Bond JS; Stretch JR; Saw RPM; Lee KJ; McCarthy WH; Scolyer RA; Thompson JF
Ann Surg Oncol; 2019 Apr; 26(4):1035-1043. PubMed ID: 30565042
[TBL] [Abstract][Full Text] [Related]
12. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
15. Relapse patterns in patients with local and regional cutaneous melanoma.
Tas F; Erturk K
Clin Transl Oncol; 2019 Apr; 21(4):412-419. PubMed ID: 30182208
[TBL] [Abstract][Full Text] [Related]
16. Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.
Dedeilia A; Lwin T; Li S; Tarantino G; Tunsiricharoengul S; Lawless A; Sharova T; Liu D; Boland GM; Cohen S
Ann Surg Oncol; 2024 Apr; 31(4):2713-2726. PubMed ID: 38158497
[TBL] [Abstract][Full Text] [Related]
17. Age as a prognostic factor in patients with localized melanoma and regional metastases.
Balch CM; Soong SJ; Gershenwald JE; Thompson JF; Coit DG; Atkins MB; Ding S; Cochran AJ; Eggermont AM; Flaherty KT; Gimotty PA; Johnson TM; Kirkwood JM; Leong SP; McMasters KM; Mihm MC; Morton DL; Ross MI; Sondak VK
Ann Surg Oncol; 2013 Nov; 20(12):3961-8. PubMed ID: 23838920
[TBL] [Abstract][Full Text] [Related]
18. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
20. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
